Anti-Human IL17A Recombinant Antibody(Secukinumab)
-
产品编号
YR1220
-
别名
科研级 Secukinumab ( 司库奴单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Secukinumab
-
规格
- 1mg
- 5mg
产品中心
Alias | 科研级 Secukinumab ( 司库奴单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Secukinumab |
Catalog Number | YR1220 |
Molecular Name | Secukinumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Secukinumab, sold under the brand name Cosentyx, is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by Novartis for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It inhibits a member of the cytokine family, interleukin 17A. |
CAS Number | 1229022-83-6 |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Molecular Weight | 147.94 kDa |
Target | IL17A[Homo sapiens] |
销售微信
官方公众号
可以介绍下你们的产品么
你们是怎么收费的呢
现在有优惠活动吗
感谢您的关注,当前客服人员不在线,请填写一下您的信息,我们会尽快和您联系。